FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588114026> ?p ?o ?g. }

• W2588114026 abstract "Abstract Interaction of auto-antibodies with platelet surface glycoproteins (GP) has been implicated in the accelerated clearance of platelets in ITP. It was recently shown, using a murine model, that the ITP induced by injection of anti-GPIIb is associated with apoptotic-like processes in platelets. These apoptotic-like processes in platelets were similar to those observed during apoptosis in nucleated cells: activation of caspase-3 (aCASP3), loss of mitochondrial inner transmembrane potential and externalisation of phosphatidylserine (PS). Administration of IVIg, that ameliorates the ITP in this model, also inhibited aCASP3 and PS externalization (Leytin et al., 2006, Br J Haematol; 133:78; Song et al., 2003, Blood; 101:3708). Whether these observations in mice are applicable to patients with ITP had not been investigated. Thus, the aim of our study was to investigate whether platelets from paediatric patients with acute ITP show an enhancement of apoptotic-like processes. Further, we examined whether the increase in platelet count in response to IVIg in these patients is accompanied by an inhibition of apoptotic-like processes in platelets. Children with clinical and laboratory diagnosis of acute ITP were enrolled in this prospective study. Severity of bleeding symptoms was assessed according to a paediatric bleeding score for ITP at the time of diagnosis and after IVIg therapy. Blood samples were obtained at these time points for measurement of platelet count and for flow cytometric analyses of platelet apoptotic-like events. Specifically, platelet aCASP3 and PS externalisation were measured in citrated platelet-rich plasma. Platelets were identified as CD42 positive events; aCASP3 was measured as % platelets with bound FLICA-FITC fluorescence; and PS exposure as % platelets with bound annexin A5-FITC fluorescence. The fraction of young, reticulated platelets (RP) was analysed using thiazole orange. All patients (median age 7.5, n = 12) presented with typical symptoms of acute ITP with a bleeding score of 2 – 3. 10 patients had platelet counts below 10’000/micro l, and 2 had platelets counts over 10’000/micro l. ITP patients had increased levels of platelets with aCASP3 (n = 11) and PS exposure (n = 9) compared with healthy control children (see Figure) and increased reticulated platelets (15.6 ± 2.7 %, n = 10; controls: 1.2 ± 0.8, n = 11). The 10 patients with platelet counts below 10,000/micro l were treated with a maximum of 3 doses of IVIg (0.4 – 0.8 g/kg/dose). All patients showed a rise in platelet counts to above 20’000/micro l and amelioration of bleeding symptoms 24 – 72 hours after IVIg administration. Concomitantly, platelet aCASP3 and PS exposure decreased (see Figure), as did RP, to 3.8 ± 1.5 % (n = 9). One patient with an initial platelet count of 18,000/micro l was not treated. This patient showed 5% positive aCASP3 platelets, 3.5 % platelets with PS exposure and 3.5% RP, similar to controls; one month later, the platelet count increased spontaneously to 60’000/micro l with 10% aCASP positive platelets, 4% platelets with PS exposure and 3 % RP. One patient was lost to follow-up. In summary, we have demonstrated enhancement of the platelet apoptotic-like processes of aCASP3 and PS externalisation in paediatric acute ITP, similar to the reported murine model. Consistent with acute ITP, platelet counts were low and levels of RP were high; after administration of IVIg, platelet counts increased whereas levels of RP decreased. IVIg administration also led to a decrease of aCASP3 and PS exposure in the patients’ platelets. Thus, amelioration of acute ITP in children by IVIg is accompanied by inhibition of enhanced apoptosis-like events in platelets. Figure A: aCASP3 in acute ITP expressed as % platelets with FLICA-FITC fluorescence. B: PS exposure in acute ITP measured as % platelets with bound annexin A5-FITC fluorescence. After IVIg administration, fractions of aCASP3 positive platelets as well as platelets exposing PS were decreased. Figure A:. aCASP3 in acute ITP expressed as % platelets with FLICA-FITC fluorescence. B: PS exposure in acute ITP measured as % platelets with bound annexin A5-FITC fluorescence. After IVIg administration, fractions of aCASP3 positive platelets as well as platelets exposing PS were decreased." @default.
• W2588114026 created "2017-02-24" @default.
• W2588114026 creator A5003872799 @default.
• W2588114026 creator A5048985547 @default.
• W2588114026 creator A5051486240 @default.
• W2588114026 creator A5072788142 @default.
• W2588114026 creator A5081654608 @default.
• W2588114026 date "2008-11-16" @default.
• W2588114026 modified "2023-09-30" @default.
• W2588114026 title "Apoptosis in Platelets from Pediatric Patients with Acute Immune Thrombocytopenic Purpura (ITP) Is Ameliorated by IV Ig." @default.
• W2588114026 doi "https://doi.org/10.1182/blood.v112.11.3417.3417" @default.
• W2588114026 hasPublicationYear "2008" @default.
• W2588114026 type Work @default.
• W2588114026 sameAs 2588114026 @default.
• W2588114026 citedByCount "3" @default.
• W2588114026 countsByYear W25881140262012 @default.
• W2588114026 crossrefType "journal-article" @default.
• W2588114026 hasAuthorship W2588114026A5003872799 @default.
• W2588114026 hasAuthorship W2588114026A5048985547 @default.
• W2588114026 hasAuthorship W2588114026A5051486240 @default.
• W2588114026 hasAuthorship W2588114026A5072788142 @default.
• W2588114026 hasAuthorship W2588114026A5081654608 @default.
• W2588114026 hasConcept C126322002 @default.
• W2588114026 hasConcept C159654299 @default.
• W2588114026 hasConcept C190283241 @default.
• W2588114026 hasConcept C190481736 @default.
• W2588114026 hasConcept C203014093 @default.
• W2588114026 hasConcept C2778918659 @default.
• W2588114026 hasConcept C2779637612 @default.
• W2588114026 hasConcept C2779771385 @default.
• W2588114026 hasConcept C3018697912 @default.
• W2588114026 hasConcept C41625074 @default.
• W2588114026 hasConcept C54355233 @default.
• W2588114026 hasConcept C55493867 @default.
• W2588114026 hasConcept C71924100 @default.
• W2588114026 hasConcept C86803240 @default.
• W2588114026 hasConcept C89560881 @default.
• W2588114026 hasConcept C90924648 @default.
• W2588114026 hasConceptScore W2588114026C126322002 @default.
• W2588114026 hasConceptScore W2588114026C159654299 @default.
• W2588114026 hasConceptScore W2588114026C190283241 @default.
• W2588114026 hasConceptScore W2588114026C190481736 @default.
• W2588114026 hasConceptScore W2588114026C203014093 @default.
• W2588114026 hasConceptScore W2588114026C2778918659 @default.
• W2588114026 hasConceptScore W2588114026C2779637612 @default.
• W2588114026 hasConceptScore W2588114026C2779771385 @default.
• W2588114026 hasConceptScore W2588114026C3018697912 @default.
• W2588114026 hasConceptScore W2588114026C41625074 @default.
• W2588114026 hasConceptScore W2588114026C54355233 @default.
• W2588114026 hasConceptScore W2588114026C55493867 @default.
• W2588114026 hasConceptScore W2588114026C71924100 @default.
• W2588114026 hasConceptScore W2588114026C86803240 @default.
• W2588114026 hasConceptScore W2588114026C89560881 @default.
• W2588114026 hasConceptScore W2588114026C90924648 @default.
• W2588114026 hasLocation W25881140261 @default.
• W2588114026 hasOpenAccess W2588114026 @default.
• W2588114026 hasPrimaryLocation W25881140261 @default.
• W2588114026 hasRelatedWork W2026003981 @default.
• W2588114026 hasRelatedWork W2047289361 @default.
• W2588114026 hasRelatedWork W2049742809 @default.
• W2588114026 hasRelatedWork W2125247175 @default.
• W2588114026 hasRelatedWork W2323313983 @default.
• W2588114026 hasRelatedWork W2324215736 @default.
• W2588114026 hasRelatedWork W2352237485 @default.
• W2588114026 hasRelatedWork W2378351508 @default.
• W2588114026 hasRelatedWork W2413980591 @default.
• W2588114026 hasRelatedWork W2551463845 @default.
• W2588114026 hasRelatedWork W2552605305 @default.
• W2588114026 hasRelatedWork W2557360792 @default.
• W2588114026 hasRelatedWork W2579641618 @default.
• W2588114026 hasRelatedWork W2594325196 @default.
• W2588114026 hasRelatedWork W2900732597 @default.
• W2588114026 hasRelatedWork W2909197722 @default.
• W2588114026 hasRelatedWork W2965515978 @default.
• W2588114026 hasRelatedWork W2979880812 @default.
• W2588114026 hasRelatedWork W3213582906 @default.
• W2588114026 hasRelatedWork W3142203360 @default.
• W2588114026 isParatext "false" @default.
• W2588114026 isRetracted "false" @default.
• W2588114026 magId "2588114026" @default.
• W2588114026 workType "article" @default.